https://pharm.it-wiegand.de/pipelines/237/pediatric-patients-aged-1-to-6-years-with-apds/2023-09-18T14:16:12+00:00https://pharm.it-wiegand.de/pipelines/238/pediatric-patients-aged-4-to-11-years-with-apds/2023-09-18T14:17:22+00:00https://pharm.it-wiegand.de/pipelines/239/extension-to-the-study-of-efficacy-of-cdz173-in-patients-with-apds-pasli/2023-09-18T14:18:12+00:00